Diabetes pill shows Real-World promise for blood sugar and weight control
NCT ID NCT04601740
Summary
This study observed how the diabetes medication Rybelsus (oral semaglutide) works for adults with type 2 diabetes in everyday medical practice. Researchers followed 145 patients in the Netherlands for 8-10 months to see how the treatment affected their blood sugar levels and body weight. The goal was to understand the real-world benefits of this once-daily pill.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Master Centre Netherlands
Alphen aan den Rijn, 2408 AV, Netherlands
Conditions
Explore the condition pages connected to this study.